Pathogenic Homozygous Mutations in the DBT Gene (c.1174A>C) Result in Maple Syrup Urine Disease in a rs12021720 Carrier

Lab Med. 2022 Nov 3;53(6):596-601. doi: 10.1093/labmed/lmac034.

Abstract

Objective: Maple syrup urine disease (MSUD; OMIM #248600) is an autosomal recessive metabolic disorder in the catabolism of branched-chain amino acids (leucine, isoleucine, and valine) and may be lethal if untreated in affected newborns.

Methods: Single-nucleotide polymorphism haplotyping and Sanger sequencing of BCKDHA, BCKDHB, and DBT genes were performed in a cohort of 10 MSUD patients.

Results: We identified a 16.6 Mb homozygous region harboring the DBT gene in an Iranian girl presenting with MSUD. Sanger sequencing revealed a pathogenic homozygous variant (NM_001918.3: c.1174A > C) in the DBT gene. We further found a controversial variant (rs12021720: c.1150 A > G) in the DBT gene. This substitution (p.Ser384Gly) is highly debated in literature. Bioinformatics and cosegregation analysis, along with identifying the real pathogenic variants (c.1174 A > C), lead to terminate these various interpretations of c.1150 A > G variant.

Conclusion: Our study introduced c.1150 A > G as a polymorphic variant, which is informative for variant databases and also helpful in molecular diagnosis.

Keywords: BCKDHA gene; BCKDHB gene; DBT gene; MSUD; mutation; rs12021720.

MeSH terms

  • 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)* / genetics
  • Female
  • Humans
  • Infant, Newborn
  • Iran
  • Maple Syrup Urine Disease* / diagnosis
  • Maple Syrup Urine Disease* / genetics
  • Mutation, Missense

Substances

  • 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)